TY - JOUR
T1 - Speculations on the future of psychiatric diagnosis
AU - Rush, A. John
AU - Ibrahim, Hisham M.
N1 - Publisher Copyright:
© 2018 Wolters Kluwer Health, Inc. All rights reserved.
PY - 2018/6
Y1 - 2018/6
N2 - The Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-V), criterion symptom listings are frequently used in clinical practice as checklists to make diagnoses. However, most DSM-V conditions are, in fact, syndromes, that is, collections of signs and symptoms that commonly occur together in the clinic. This report discusses the value of syndromes in medicine and psychiatry. It is argued that a more precise future enumeration of brain circuits and the pathogenesis of psychiatric conditions will help us better understand and treat psychiatric syndromes, but they are unlikely to eliminate the need to categorize psychiatric conditions. We expect that biomarkers will play an increasingly critical role in psychiatric diagnosis. Beyond a better mechanistic understanding of the DSM-V syndromes, future diagnostic efforts will need to increase the focus on function and address risk factors for nonresponse and relapse. We suggest that new artificial intelligence advances will increase the efficiency and acceptability of psychiatric diagnosis and assist with treatment delivery.
AB - The Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-V), criterion symptom listings are frequently used in clinical practice as checklists to make diagnoses. However, most DSM-V conditions are, in fact, syndromes, that is, collections of signs and symptoms that commonly occur together in the clinic. This report discusses the value of syndromes in medicine and psychiatry. It is argued that a more precise future enumeration of brain circuits and the pathogenesis of psychiatric conditions will help us better understand and treat psychiatric syndromes, but they are unlikely to eliminate the need to categorize psychiatric conditions. We expect that biomarkers will play an increasingly critical role in psychiatric diagnosis. Beyond a better mechanistic understanding of the DSM-V syndromes, future diagnostic efforts will need to increase the focus on function and address risk factors for nonresponse and relapse. We suggest that new artificial intelligence advances will increase the efficiency and acceptability of psychiatric diagnosis and assist with treatment delivery.
KW - Biomarkers
KW - Psychiatric diagnosis
KW - Psychiatric syndrome
UR - http://www.scopus.com/inward/record.url?scp=85051826213&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85051826213&partnerID=8YFLogxK
U2 - 10.1097/NMD.0000000000000821
DO - 10.1097/NMD.0000000000000821
M3 - Article
C2 - 29781887
AN - SCOPUS:85051826213
SN - 0022-3018
VL - 206
SP - 481
EP - 487
JO - Journal of Nervous and Mental Disease
JF - Journal of Nervous and Mental Disease
IS - 6
ER -